Trinity Biotech (TRIB) Other Non-Current Liabilities (2009 - 2025)
Trinity Biotech (TRIB) posted quarterly Other Non-Current Liabilities of $781000.0 for Q4 2025, up 941.33% year-on-year from $75000.0 in Q4 2024, and down 57.58% on a QoQ basis from $1.8 million in Q2 2025.
Trinity Biotech (TRIB) Other Non-Current Liabilities (2009 - 2025) Analysis & Trends
Trinity Biotech (TRIB) has reported Other Non-Current Liabilities for 17 consecutive years, with $781000.0 the latest figure, recorded in Q4 2025.
- Quarterly Other Non-Current Liabilities rose 941.33% year-over-year to $781000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $781000.0 (up 941.33% YoY) and the FY2025 annual result came in at $781000.0, up 941.33% from the prior year.
- Other Non-Current Liabilities retreated to $781000.0 in Q4 2025 per TRIB's latest filing, from $1.8 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for TRIB reached as high as $1.8 million in Q2 2025 and fell as low as $50000.0 in Q4 2021.
- A 5-year average of $245833.3 and a median of $50000.0 in 2021 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities sank 87.98% — and 2025, when it surged 3582.0%.
- Year by year, Other Non-Current Liabilities stood at $50000.0 in 2021, then changed by 0.0% to $50000.0 in 2022, then changed by 0.0% to $50000.0 in 2023, then jumped by 50.0% to $75000.0 in 2024, then jumped by 941.33% to $781000.0 in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $781000.0, $1.8 million, and $75000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 781,000.00 |
| Jun 30, 2025 | 1.84 Mn |
| Dec 31, 2024 | 75,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 50,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | 376,000.00 |
| Jun 30, 2021 | 376,000.00 |
| Mar 31, 2021 | 376,000.00 |
| Dec 31, 2020 | 416,000.00 |
| Sep 30, 2020 | 50,000.00 |